Evidence map›Paper›PMID 38491411›Full record

Trial reportBMC psychiatry2024

One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial.

Mei-Rong Pan, Min Dong, Shi-Yu Zhang, Lu Liu, Hai-Mei Li, Yu-Feng Wang, Qiu-Jin Qian

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07029425 (Effectiveness of Manual Therapy in the Treatment of Attention Deficit Hyperactivity Disorder), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07029425 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Manual Therapy in the Treatment of Attention Deficit Hyperactivity Disorder

TypeinterventionalSponsorJJ JIMENEZ-REJANORan2025 to 2026Enrolled60ConditionsAttention Deficit Hyperactivity Disorder (ADHD)ArmsProcedure: craniosacral therapy techniques., Placebo Group
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mei-Rong Pan *Peking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Min Dong *Peking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Shi-Yu ZhangPeking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Lu LiuPeking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Hai-Mei LiPeking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Yu-Feng WangPeking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
Qiu-Jin QianPeking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China. qianqiujin@bjmu.edu.cn.ORCID 0000-0001-5060-3772
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe long-term effectiveness of cognitive behavioural therapy (CBT) in medicated attention-deficit/hyperactivity disorder (ADHD) adults with residual symptoms needs to be verified across multiple dimensions, especially with respect to maladaptive cognitions and psychological quality of life (QoL). An exploration of the mechanisms underlying the additive benefits of CBT on QoL in clinical samples may be helpful for a better understanding of the CBT conceptual model and how CBT works in medicated ADHD.

methodsWe conducted a secondary analysis of a randomised controlled trial including 98 medicated ADHD adults with residual symptoms who were randomly allocated to the CBT combined with medication (CBT + M) group or the medication (M)-only group. Outcomes included ADHD-core symptoms (ADHD Rating Scale), depression symptoms (Self-rating Depression Scale), maladaptive cognitions (Automatic Thoughts Questionnaire and Dysfunctional Attitude Scale), and psychological QoL (World Health Organization Quality of Life-Brief Version-psychological domain). Mixed linear models (MLMs) were used to analyse the long-term effectiveness at one-year follow-up, and structural equation modeling (SEM) was performed to explore the potential mechanisms of CBT on psychological QoL.

resultsADHD patients in the CBT + M group outperformed the M-only group in reduction of ADHD core symptoms (d = 0.491), depression symptoms (d = 0.570), a trend of reduction of maladaptive cognitions (d = 0.387 and 0.395, respectively), and improvement of psychological QoL (d = - 0.433). The changes in above dimensions correlated with each other (r = 0.201 ~ 0.636). The influence of CBT on QoL was mediated through the following four pathways: 1) changes in ADHD core symptoms; 2) changes in depressive symptoms; 3) changes in depressive symptoms and then maladaptive cognitions; and 4) changes firstly in depressive symptoms, maladaptive cognitions, and then ADHD core symptoms.

conclusionsThe long-term effectiveness of CBT in medicated ADHD adults with residual symptoms was further confirmed. The CBT conceptual model was verified in clinical samples, which would be helpful for a deeper understanding of how CBT works for a better psychological QoL outcome.

trial registrationChiCTR1900021705 (2019-03-05).

Indexed as

Attention Deficit Disorder with HyperactivityCognitive Behavioral TherapyAdultFollow-Up StudiesHumansQuality of LifeTreatment OutcomeAdultAttention-deficit/hyperactivity disorderCognitive behavioural therapyMaladaptive cognitionsMediation analysisQuality of life

Identifiers

PMID38491411
PMCPMC10943890
OpenAlexW4392884502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.